1 Murphy G,Lisnevskaia L,Isenberg D. Systemic lupus erythematosus and other autoimmune rheumatic diseases:challenges to treatment[J]. Lancet,2013,382(9894): 809-818. 2 Frieri M. Mechanisms of disease for the clinician: systemic lupus erythematosus[J]. Ann Allergy Asthma Immunol,2013,110(4): 228-232. 3 Jayakanthan Kabeerdoss,Nikhil Gupta,Sandhya Pulukool,et al. Anti-C1q Antibody is Associated with Renal and Cutaneous Manifestations in Asian Indian Patients with Systemic Lupus Erythematosus[J]. J Clin Diagn Res,2017,11(3): OC39-OC42. 4 van Schaarenburg R A,Magro-Checa C,Bakker J A,et al. C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus[J]. Front Immunol,2016,7: 647. 5 Trotter K,Clark M R,Liarski V M. Overview of Pathophysiology and Treatment of Human Lupus Nephritis[J]. Curr Opin Rheumatol,2016,28(5): 460-467. 6 Raja R,Chapman P T,O'Donnell J L,et al. Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association classification criteria for rheumatoid arthritis in an early arthritis cohort in New Zealand[J]. J Rheumatol,2012,39(11): 2098-2103. 7 Ghodke-Puranik Y,Niewold T B. Immunogenetics of Systemic Lupus Erythematosus:A Comprehensive Review[J]. J Autoimmun,2015,64:125-136. 8 Mak A,Kow N Y. The Pathology of T Cells in Systemic Lupus Erythematosus[J]. J Immunol Res,2014,2014:419029. 9 Kyttaris V C. Systemic Lupus Erythematosus:From Genes to Organ Damage[J]. Methods Mol Biol,2010,662:265-283. 10 Orbai A M,Truedsson L,Sturfelt G. Anti-C1q Antibodies in Systemic Lupus Erythematosus[J]. Lupus,2015,24(1): 42-49. 11 Prechl J,Czirják L. The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability[J]. F1000Res,2015,4:24. 12 Chi S,Yu Y,Shi J,et al. Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis[J]. Dis Markers,2015,2015: 450351. 13 Cozzani E,Drosera M,Gasparini G,et al. Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects[J]. Autoimmune Dis,2014,2014: 321359. 14 Gatto M,Iaccarino L,Ghirardello A,et al. Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies:A comprehensive review[J]. J Autoimmun,2016,69:1-11. 15 Sakakibara S,Arimori T,Yamashita Ket al. Clonal evolution and antigen recognition of anti-nuclear antibodies in acute systemic lupus erythematosus[J]. Sci Rep,2017,7(1):16428. 16 Al-Mayouf S M,AlSaleem A,AlMutairi N,et al. Monogenic interferonopathies:Phenotypic and genotypic findings of CANDLE syndrome and its overlap with C1q deficient SLE[J]. Int J Rheum Dis,2018,21(1): 208-213. |